Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1111/JNC.14682 | ||||
| Año | 2019 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Insulin resistance has negative consequences on the physiological functioning of the nervous system. The appearance of type 3 diabetes in the brain leads to the development of the sporadic form of Alzheimer's disease. The c-Jun N-terminal kinases (JNK), a subfamily of the Mitogen Activated Protein Kinases, are enzymes composed by three different isoforms with differential modulatory activity against the insulin receptor (IR) and its substrate. This research focused on understanding the regulatory role of JNK2 on the IR, as well as study the effect of a high-fat diet (HFD) in the brain. Our observations determined how JNK2 ablation did not induce compensatory responses in the expression of the other isoforms but led to an increase in JNKs total activity. HFD-fed animals also showed an increased activity profile of the JNKs. These animals also displayed endoplasmic reticulum stress and up-regulation of the protein tyrosine phosphatase 1B (PTP1B) and the suppressor of cytokine signalling 3 protein. Consequently, a reduction in insulin sensitivity was detected and it is correlated with a decrease on the signalling of the IR. Moreover, cognitive impairment was observed in all groups but only wild-type genotype animals fed with HFD showed neuroinflammatory responses. In conclusion, HFD and JNK2 absence cause alterations in normal cognitive activity by altering the signalling of the IR. These affectations are related to the appearance of endoplasmic reticulum stress and an increase in the levels of inhibitory proteins like PTP1B and suppressor of cytokine signalling 3 protein.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Busquets, Oriol | Hombre |
Univ Barcelona - España
Univ Rovira & Virgili - España Inst Salud Carlos III - España Universitat de Barcelona - España Universitat Rovira i Virgili, Facultat de Medicina i Ciencies de la Salut - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 2 | Eritja, Auria | - |
Univ Barcelona - España
Universitat de Barcelona - España |
| 3 | Lopez, Blanca M. | Mujer |
Univ Barcelona - España
Universitat de Barcelona - España |
| 4 | Ettcheto, Miren | Mujer |
Univ Barcelona - España
Univ Rovira & Virgili - España Inst Salud Carlos III - España Universitat de Barcelona - España Universitat Rovira i Virgili, Facultat de Medicina i Ciencies de la Salut - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 5 | Regina Manzine, Patricia | Mujer |
Univ Barcelona - España
Fed Univ Sao Carlos UFSCar - Brasil Universitat de Barcelona - España Universidade Federal de São Carlos - Brasil |
| 6 | Sureda, Francesc X. | Hombre |
Univ Guadalajara - México
Div Neurociencias - México Universitat de Barcelona - España Universidad de Guadalajara - México |
| 7 | Verdaguer, Ester | Mujer |
Inst Salud Carlos III - España
Univ Barcelona - España CIBER Enfermedades Neurodegenerativas - España Universitat de Barcelona - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 8 | Oquequi, Jordi | Hombre |
Universidad Autónoma de Chile - Chile
|
| 9 | Vazquez-Carrera, Manuel | Hombre |
Univ Barcelona - España
Inst Salud Carlos III - España IR SJD - España Universitat de Barcelona - España Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas - España Institut de Recerca Sant Joan de Déu - España Institut de Recerca Sant Joan de Déu (IR-SJD) - España |
| 10 | Auladell, Carme | Mujer |
Inst Salud Carlos III - España
Univ Barcelona - España CIBER Enfermedades Neurodegenerativas - España Universitat de Barcelona - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 11 | Folch, Jaume | Hombre |
Univ Rovira & Virgili - España
Inst Salud Carlos III - España Universitat Rovira i Virgili, Facultat de Medicina i Ciencies de la Salut - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| 12 | Camins, Antoni | Hombre |
Univ Barcelona - España
Inst Salud Carlos III - España Universitat de Barcelona - España CIBER Enfermedades Neurodegenerativas - España Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas - España |
| Fuente |
|---|
| Consejo Nacional de Ciencia y Tecnología |
| Spanish Ministry of Science and Innovation |
| Spanish Ministerio de Economía y Competitividad |
| Ministerio de Economía y Competitividad |
| Fundação de Amparo à Pesquisa do Estado de São Paulo |
| National Institutes of Health |
| Generalitat de Catalunya |
| Ministerio de Ciencia e Innovación |
| Instituto de Salud Carlos III |
| Fundação de Amparo à Pesquisa do Estado de São Paulo |
| Ministerio de Ciencia e Innovación |
| Ministerio de EconomÃa y Competitividad |
| Consejo Nacional de Ciencia y Tecnología, Paraguay |
| CIBER de Enfermedades Neurodegenerativas (CIBERNED) |
| Instituto Nacional de Ciberseguridad |
| Sao Paulo Research Foundation (FAPESP) - Brazil |
| CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) |
| Doctoral Program in Sciences in Molecular Biology in Medicine, LGAC Molecular Bases of Chronic Diseases-Degenerative and its Applications |
| Postdoctoral fellowship CONACYT |
| Consejo Nacional de Ciencia y TecnologÃa, Paraguay |
| CIBER de Enfermedades Neurodegenerativas |
| Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas |
| Spanish Ministerio de Economía y Compet-itividad |
| CIBER de Diabetes y Enfermedades Metabólicas Asociadas |
| Agradecimiento |
|---|
| OB, AC, ME, CA, EV and JF belong to 2014SGR 525 from Generalitat de Catalunya. Also, this study was partly supported by funds from the Spanish Ministerio de Economia y Competitividad (SAF2017-84283-R to AC, SAF2015-64146-R to MVC), the Generalitat de Catalunya (2014SGR-525 to AC and 2014SGR-13 to MVC) and Spanish Ministry of Science and Innovation (PI2016/01). CIBER de Enfermedades Neurodegenerativas (CIBERNED) (Grant CB06/05/2004 to AC) and CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) (Grant CB07/08/0003 to MVC; Instituto de Salud Carlos III Project). RDCT is supported by Postdoctoral fellowship CONACYT No. 298337 and the Doctoral Program in Sciences in Molecular Biology in Medicine, LGAC Molecular Bases of Chronic Diseases-Degenerative and its Applications (000091, PNPC, CONACyT). PRM is supported by grants 2015/26084-1 and 2017/13224-5, Sao Paulo Research Foundation (FAPESP) - Brazil. No authors have any actual or potential conflicts of interest including any financial, personal or other relationships with other people or organizations. All authors have reviewed the contents of the manuscript being submitted, approve of its contents and validate the accuracy of the data. |
| OB, AC, ME, CA, EV and JF belong to 2014SGR 525 from Generalitat de Catalunya. Also, this study was partly supported by funds from the Spanish Ministerio de Economía y Compet-itividad (SAF2017-84283-R to AC, SAF2015-64146-R to MVC), the Generalitat de Catalunya (2014SGR-525 to AC and 2014SGR-13 to MVC) and Spanish Ministry of Science and Innovation (PI2016/01). CIBER de Enfermedades Neurodegener-ativas (CIBERNED) (Grant CB06/05/2004 to AC) and CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) (Grant CB07/08/0003 to MVC; Instituto de Salud Carlos III Project). RDCT is supported by Postdoctoral fellowship CONACYT No. 298337 and the Doctoral Program in Sciences in Molecular Biology in Medicine, LGAC Molecular Bases of Chronic Diseases-Degenerative and its Applications (000091, PNPC, CONACyT). PRM is supported by grants 2015/26084-1 and 2017/13224-5, São Paulo Research Foundation (FAPESP) – Brazil. No authors have any actual or potential conflicts of interest including any financial, personal or other relationships with other people or organizations. All authors have reviewed the contents of the manuscript being submitted, approve of its contents and validate the accuracy of the data. |